Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Linz

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
American Journal of Hypertension|April 1, 1989
Cardiac renin-angiotensin systemW Linz, B Schölkens, K Lindpaintner, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarctionG Wiemer, G Itter, T Malinski, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Local inhibition of bradykinin degradation in ischemic heartsW Linz, P A Martorana, B A Schölkens
Zeitschrift Fur Kardiologie|January 1, 1988
[Pharmacologic modification of the converting enzyme--local and systemic effects on the heart and blood vessels]B A Schölkens, R H Becker, W Linz
Basic Research in Cardiology|July 1, 1991
Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors?P A Martorana, W Linz, B A Schölkens
Circulation Research|September 17, 1999
Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive ratsH Ruetten, U Zabel, W Linz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Low-dose felodipine treatment attenuates endothelial dysfunction in rabbits fed an atherogenic dietR H Becker, W Linz, G Wiemer, et al.
Laboratory Animals|May 20, 2005
The isolated working heart model in infarcted rat heartsG Itter, W Jung, B A Schoelkens, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2000
Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive ratsW Linz, H Heitsch, B A Schölkens, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1995
Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reductionW Linz, P Gohlke, T Unger, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Hypertension|April 1, 1989
Cardiac renin-angiotensin systemW Linz, B Schölkens, K Lindpaintner, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarctionG Wiemer, G Itter, T Malinski, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Local inhibition of bradykinin degradation in ischemic heartsW Linz, P A Martorana, B A Schölkens
Zeitschrift Fur Kardiologie|January 1, 1988
[Pharmacologic modification of the converting enzyme--local and systemic effects on the heart and blood vessels]B A Schölkens, R H Becker, W Linz
Basic Research in Cardiology|July 1, 1991
Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors?P A Martorana, W Linz, B A Schölkens
Circulation Research|September 17, 1999
Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive ratsH Ruetten, U Zabel, W Linz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Low-dose felodipine treatment attenuates endothelial dysfunction in rabbits fed an atherogenic dietR H Becker, W Linz, G Wiemer, et al.
Laboratory Animals|May 20, 2005
The isolated working heart model in infarcted rat heartsG Itter, W Jung, B A Schoelkens, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2000
Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive ratsW Linz, H Heitsch, B A Schölkens, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1995
Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reductionW Linz, P Gohlke, T Unger, et al.
Pageof 13